ND-09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR-ABL signaling (vol 46, 136, 2021)

被引：0
|
作者：
Liu, Yan-Hong
Zhu, Man
Lei, Pan-Pan
Pan, Xiao-Yan
Ma, Wei-Na
机构：
来源：
ONCOLOGY REPORTS | 2023年 / 49卷 / 05期
关键词：
D O I：
10.3892/or.2023.8518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Luteoloside Inhibits Proliferation of Human Chronic Myeloid Leukemia K562 Cells by Inducing G2/M Phase Cell Cycle Arrest and Apoptosis
    Shao, Jun-Li
    Liang, Hai-Rong
    Dai, Juan-Xiu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (01) : 39 - 45
  • [42] Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T3151 Bcr-Abl mutant by a redox-mediated mechanism
    Corrado, Chiara
    Raimondo, Stefania
    Flugy, Anna Maria
    Fontana, Simona
    Santoro, Alessandra
    Stassi, Giorgio
    Marfia, Anna
    Iovino, Flora
    Arlinghaus, Ralph
    Kohn, Elise C.
    De Leo, Giacomo
    Alessandro, Riccardo
    CANCER LETTERS, 2011, 300 (02) : 205 - 214
  • [43] Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation
    JS Damiano
    LA Hazlehurst
    WS Dalton
    Leukemia, 2001, 15 : 1232 - 1239
  • [44] Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation
    Damiano, JS
    Hazlehurst, LA
    Dalton, WS
    LEUKEMIA, 2001, 15 (08) : 1232 - 1239
  • [45] Eupolyphaga sinensis Walker inhibits human chronic myeloid leukemia cell K562 growth by inducing G2-M phase cell cycle arrest and targeting EGFR signaling pathway and in S180 tumor-bearing mice
    Dai, Bingling
    Zhan, Yingzhuan
    Qi, Junpeng
    Zhang, Yanmin
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2014, 37 (03) : 1177 - 1185
  • [46] Anti-cancer activity of brucine loaded Cu(OH)2/ZnO nanoparticles against chronic myeloid leukemia cell line (K562) via apoptotic signaling pathway
    Althafar, Ziyad M.
    Mujamammi, Ahmed H.
    Alafaleq, Nouf O.
    Gohal, Gassem
    Alsahly, Musaad B.
    Alsufayan, Thamer A.
    Sabi, Essa M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 101
  • [47] Tumor suppressor miR-520a inhibits cell growth by negatively regulating PI3K/AKT signaling pathway in acute myeloid leukemia
    Xiao, Jing
    Wan, Fang
    Tian, Lin
    Li, Yao
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (07): : 729 - 738
  • [48] TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β-catenin/TCF7/ABC transporter signaling axis
    Zhang, Hui
    Wang, Yonghong
    Yang, Hao
    Huang, Zhenglan
    Wang, Xin
    Feng, Wenli
    ONCOLOGY REPORTS, 2021, 45 (02) : 557 - 568
  • [49] Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells
    Sumi, Kazuya
    Tago, Kenji
    Nakazawa, Yosuke
    Takahashi, Kyoko
    Ohe, Tomoyuki
    Mashino, Tadahiko
    Funakoshi-Tago, Megumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [50] Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells (vol 2013, 805639, 2013)
    Jung, Ji Hoon
    Kwon, Tae-Rin
    Jeong, Soo-Jin
    Kim, Eun-Ok
    Sohn, Eun Jung
    Yun, Miyong
    Kim, Sung-Hoon
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
12345